FBLG
Price
$0.95
Change
+$0.01 (+1.06%)
Updated
Nov 9 closing price
Capitalization
6.56M
3 days until earnings call
Intraday BUY SELL Signals
PEPG
Price
$2.39
Change
-$0.08 (-3.24%)
Updated
Nov 9 closing price
Capitalization
171.07M
One day until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

FBLG vs PEPG

FBLG vs PEPG Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
FBLG vs. PEPG commentary
Nov 10, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FBLG is a StrongBuy and PEPG is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for FBLG with price predictions
Nov 09, 2026

FBLG's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for FBLG turned positive on October 27, 2026. Looking at past instances where FBLG's MACD turned positive, the stock continued to rise in 23 of 24 cases over the following month. The odds of a continued upward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where FBLG's RSI Oscillator exited the oversold zone, 22 of 27 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 81%.

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 31 of 35 cases where FBLG's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 89%.

The Momentum Indicator moved above the 0 level on November 09, 2026. You may want to consider a long position or call options on FBLG as a result. In 35 of 49 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 71%.

Following a +6.45% 3-day Advance, the price is estimated to grow further. Considering data from situations where FBLG advanced for three days, in 104 of 128 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.

FBLG may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The 10-day moving average for FBLG crossed bearishly below the 50-day moving average on October 06, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 5 of 5 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where FBLG declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for FBLG entered a downward trend on November 04, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 61 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.414) is normal, around the industry mean (3.498). P/E Ratio (-0.185) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (440.869).

The Tickeron PE Growth Rating for this company is 73 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 77 (best 1 - 100 worst), indicating slightly worse than average price growth. FBLG’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. FBLG’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

A.I.Advisor
a Summary for PEPG with price predictions
Nov 09, 2026

Momentum Indicator for PEPG turns negative, indicating new downward trend

PEPG saw its Momentum Indicator move below the 0 level on October 29, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 86 similar instances where the indicator turned negative. In 80 of the 86 cases, the stock moved further down in the following days. The odds of a decline are at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for PEPG turned negative on October 30, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 40 similar instances when the indicator turned negative. In 35 of the 40 cases the stock turned lower in the days that followed. This puts the odds of success at 88%.

PEPG moved below its 50-day moving average on October 21, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PEPG declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

PEPG broke above its upper Bollinger Band on October 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where PEPG's RSI Indicator exited the oversold zone, 18 of 22 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 82%.

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 54 of 59 cases where PEPG's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 90%.

Following a +10.38% 3-day Advance, the price is estimated to grow further. Considering data from situations where PEPG advanced for three days, in 198 of 229 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.

The Aroon Indicator entered an Uptrend today. In 104 of 112 cases where PEPG Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 90%.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 34 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.431) is normal, around the industry mean (3.498). P/E Ratio (-2.470) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (440.869).

The Tickeron Price Growth Rating for this company is 55 (best 1 - 100 worst), indicating steady price growth. PEPG’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 61 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PEPG’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

TECHNICAL ANALYSIS
Technical Analysis
FBLGPEPG
RSI
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 6 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
71%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
88%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
86%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
87%
Advances
ODDS (%)
Bullish Trend 7 days ago
81%
Bullish Trend 21 days ago
86%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
86%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
90%
COMPARISON
Comparison
Nov 10, 2026
Stock price -- (FBLG: $0.94 vs. PEPG: $2.39)
Brand notoriety: FBLG and PEPG are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FBLG: 21% vs. PEPG: 146%
Market capitalization -- FBLG: $6.56M vs. PEPG: $171.07M
FBLG [@Biotechnology] is valued at $6.56M. PEPG’s [@Biotechnology] market capitalization is $171.07M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $138.67B. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FBLG’s FA Score shows that 0 FA rating(s) are green while PEPG’s FA Score has 0 green FA rating(s).

  • FBLG’s FA Score: 0 green, 5 red.
  • PEPG’s FA Score: 0 green, 5 red.
According to our system of comparison, PEPG is a better buy in the long-term than FBLG.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FBLG’s TA Score shows that 5 TA indicator(s) are bullish while PEPG’s TA Score has 4 bullish TA indicator(s).

  • FBLG’s TA Score: 5 bullish, 4 bearish.
  • PEPG’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, FBLG is a better buy in the short-term than PEPG.

Price Growth

FBLG (@Biotechnology) experienced а +1.35% price change this week, while PEPG (@Biotechnology) price change was +1.70% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.97%. For the same industry, the average monthly price growth was -8.33%, and the average quarterly price growth was +85.08%.

Reported Earning Dates

PEPG is expected to report earnings on Nov 11, 2026.

Industries' Descriptions

@Biotechnology (+2.97% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
Interact to see
Advertisement

FBLG and

Correlation & Price change

A.I.dvisor indicates that over the last year, FBLG has been loosely correlated with PEPG. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if FBLG jumps, then PEPG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FBLG
1D Price
Change %
FBLG100%
+0.79%
PEPG - FBLG
37%
Loosely correlated
-3.24%
ATOS - FBLG
29%
Poorly correlated
+0.47%
ZNTL - FBLG
28%
Poorly correlated
+1.16%
CELC - FBLG
28%
Poorly correlated
+5.36%
REVB - FBLG
27%
Poorly correlated
+4.90%
More

PEPG and

Correlation & Price change

A.I.dvisor indicates that over the last year, PEPG has been loosely correlated with NCEL. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if PEPG jumps, then NCEL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PEPG
1D Price
Change %
PEPG100%
-3.24%
NCEL - PEPG
38%
Loosely correlated
-0.36%
FBLG - PEPG
37%
Loosely correlated
+0.79%
CDT - PEPG
32%
Poorly correlated
-35.87%
CLDX - PEPG
31%
Poorly correlated
+4.59%
SLDB - PEPG
30%
Poorly correlated
+6.53%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FITE107.325.35
+5.25%
State Street SPDR S&P Kensho Future Security ETF (FITE)
MISL42.171.82
+4.51%
First Trust Indxx Aerospace & Defense ETF (MISL)
RESM23.640.69
+3.01%
Columbia Research Enhanced Small Cap ETF (RESM)
BPRE12.480.26
+2.13%
Bluerock Private Real Estate Fund
PBDE31.800.47
+1.49%
PGIM S&P 500 Buffer 20 ETF - December (PBDE)